+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ONESOURCE

OneSource Specialty Pharma Share Price

 
54.90% Gain from 52W Low

 

OneSource Specialty Pharma live price: ₹1,637.30. It opened at ₹1,678 vs previous close ₹1,672; intraday high/low: ₹1,690/₹1,635. The 50 & 200 DMA stand at ₹1,659.80/₹1,636.80.

OneSource Specialty Pharma Performance

  • Today's Low
  • ₹1,635
  • Today's High
  • ₹1,690
  • 52 Week Low
  • ₹1,057
  • 52 Week High
  • ₹2,027
  • Open Price₹1,678
  • Previous Close₹1,672
  • Volume61,431
  • 50 DMA₹1,659.80
  • 100 DMA₹1,641.30
  • 200 DMA₹1,636.80

OneSource Specialty Pharma Chart

Investment Returns

  • Over 1 Month + 1.39%
  • Over 3 Month + 1.63%
  • Over 6 Month + 5.89%
  • Over 1 Year -15.96%

Smart Investing Starts Here Start SIP with OneSource Specialty Pharma for Steady Growth!

Invest Now

OneSource Specialty Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -254.4
  • PEG Ratio
  • 0.8
  • Market Cap Cr
  • 18,775
  • P/B Ratio
  • 3.2
  • Average True Range
  • 72.1
  • EPS
  • -6.4
  • Dividend Yield
  • 0
  • MACD Signal
  • -2.7
  • RSI
  • 52.22
  • MFI
  • 39.54

Latest Stock News Updates

Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Earnings Call to be held on July 25, 2026.

Onesource Specialty Pharma Ltd - 544292 - Board Meeting Intimation for Approval Of The Unaudited Financial Results For The Quarter Ended June 30, 2026.

Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 ,inter alia, to consider and approve Unaudited financial results (Standalone and Consolidated) for the quarter ended June 30, 2026.

OneSource Specialty Pharma ties up with Germany's Formycon for Biosimilar manufacturing

Under the agreement, OneSource will provide integrated Drug Substance and Drug Product manufacturing for Formycon's biosimilar programs from its biologics facility in Bangalore

OneSource Specialty Pharma Financials

OneSource Specialty Pharma Technicals

EMA & SMA

Current Price
₹1,637.30
-34.2 (-2.05%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹1,654.40
  • 50 Day
  • ₹1,659.80
  • 100 Day
  • ₹1,641.30
  • 200 Day
  • ₹1,636.80

Resistance and Support

1654.07 Pivot Speed
  • R3 1,820.60
  • R2 1,750.30
  • R1 1,710.90
  • S1 1,601.20
  • S2 1,530.90
  • S3 1,491.50

OneSource Specialty Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-24 Quarterly Results
2026-05-13 Audited Results
2026-01-23 Quarterly Results
2025-11-11 Quarterly Results
2025-08-04 Quarterly Results

OneSource Specialty Pharma Shareholding Pattern

30.48%
26.95%
19.19%
12.98%
10.39%

About OneSource Specialty Pharma

OneSource Specialty Pharma is engaged in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. OneSource also offers end-to-end Contract Development and Manufacturing Operations services across all phases of pre-clinical and clinical development and commercial supply of biologics. View More
  • NSE Symbol
  • ONESOURCE
  • BSE Symbol
  • 544292
  • Executive Director,Managing Director,Chief Executive Officer
  • Neeraj Sharma
  • ISIN
  • INE013P01021

Similar Stocks to OneSource Specialty Pharma

OneSource Specialty Pharma FAQs

OneSource Specialty Pharma share price is ₹1,637 As on 23 July, 2026 | 13:26

The Market Cap of OneSource Specialty Pharma is ₹18774.9 Cr As on 23 July, 2026 | 13:26

The P/E ratio of OneSource Specialty Pharma is -254.4 As on 23 July, 2026 | 13:26

The PB ratio of OneSource Specialty Pharma is 3.2 As on 23 July, 2026 | 13:26

The 52 week High & Low of OneSource Specialty Pharma is ₹2026.5/₹1057 respectively As on 23 July, 2026 | 13:26

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23